October Pharma S.A.E (EGX: OCPH)
Egypt
· Delayed Price · Currency is EGP 108.23
0.00 (0.00%)
At close: Nov 20, 2024
October Pharma S.A.E Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 216.18 | 182.13 | 130.75 | 119.79 | 88.26 | 33.83 | Upgrade
|
| Depreciation & Amortization | 21.78 | 22.11 | 22 | 20.8 | 18.82 | 16.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.86 | -0.24 | -0.34 | - | -0.05 | -0.14 | Upgrade
|
| Provision & Write-off of Bad Debts | 5.76 | 5.76 | 0.94 | 2.21 | - | - | Upgrade
|
| Other Operating Activities | 73.05 | 102.47 | 42.76 | 55.6 | 40.1 | 6.4 | Upgrade
|
| Change in Accounts Receivable | 15.03 | -70.98 | -49.56 | -12.86 | -11.11 | -27.1 | Upgrade
|
| Change in Inventory | 4.12 | 84.44 | -89.2 | -26.75 | -52.84 | 8.06 | Upgrade
|
| Change in Accounts Payable | 44.78 | -10.28 | 50.46 | -4.59 | -2.45 | 8.08 | Upgrade
|
| Change in Other Net Operating Assets | -279.88 | -162.54 | -200.13 | 107.93 | -27.44 | 50.31 | Upgrade
|
| Operating Cash Flow | 98.96 | 152.87 | -92.33 | 262.13 | 53.3 | 96.06 | Upgrade
|
| Operating Cash Flow Growth | 29.66% | - | - | 391.81% | -44.52% | - | Upgrade
|
| Capital Expenditures | -37.16 | -35.31 | -92.67 | -19.7 | -5.65 | -33.23 | Upgrade
|
| Sale of Property, Plant & Equipment | -62.51 | 0.25 | 0.36 | - | 0.05 | 0.16 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.35 | -1.99 | -1.7 | -1.38 | - | Upgrade
|
| Other Investing Activities | -404.9 | - | - | - | - | - | Upgrade
|
| Investing Cash Flow | -504.57 | -35.4 | -94.31 | -21.4 | -6.98 | -33.06 | Upgrade
|
| Short-Term Debt Issued | - | 13.69 | 188.26 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 60.92 | - | - | - | Upgrade
|
| Total Debt Issued | 178.31 | 13.69 | 249.19 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -136.65 | -2.4 | -27.25 | Upgrade
|
| Long-Term Debt Repaid | - | -12.05 | - | -24.83 | -12.02 | -22.78 | Upgrade
|
| Total Debt Repaid | 32.75 | -12.05 | - | -161.48 | -14.42 | -50.03 | Upgrade
|
| Net Debt Issued (Repaid) | 211.06 | 1.64 | 249.19 | -161.48 | -14.42 | -50.03 | Upgrade
|
| Common Dividends Paid | -55.8 | -17.95 | -44.66 | -34.19 | -14.86 | -9.92 | Upgrade
|
| Other Financing Activities | -535.41 | -62.77 | -27.7 | -30.2 | -31.91 | - | Upgrade
|
| Financing Cash Flow | -380.15 | -79.09 | 176.83 | -225.87 | -61.18 | -59.96 | Upgrade
|
| Net Cash Flow | 21.03 | 38.38 | -9.81 | 14.86 | -14.86 | 3.04 | Upgrade
|
| Free Cash Flow | 61.8 | 117.56 | -185 | 242.43 | 47.65 | 62.83 | Upgrade
|
| Free Cash Flow Growth | 20.93% | - | - | 408.79% | -24.17% | - | Upgrade
|
| Free Cash Flow Margin | 5.18% | 11.62% | -25.43% | 37.01% | 8.77% | 12.01% | Upgrade
|
| Free Cash Flow Per Share | 2.99 | 9.80 | -15.42 | 20.20 | 3.97 | 5.24 | Upgrade
|
| Cash Interest Paid | - | - | - | 30.2 | 31.91 | - | Upgrade
|
| Cash Income Tax Paid | 41.29 | 41.29 | 37.37 | 22.7 | 10.53 | 6.48 | Upgrade
|
| Levered Free Cash Flow | 445.19 | 24.95 | -239 | 200.33 | -9.99 | 58.7 | Upgrade
|
| Unlevered Free Cash Flow | 515.39 | 64.18 | -221.68 | 219.2 | 9.95 | 88.96 | Upgrade
|
| Change in Net Working Capital | 273.72 | 114.19 | 273.54 | -97.59 | 92.49 | -44.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.